Wordt geladen...
Subclinical Pre-Treatment Sensory Deficits Appear to Predict the Development of Pain and Numbnessin Patients with Multiple Myeloma Undergoing Chemotherapy
PURPOSE: Chemotherapy-induced peripheral neuropathy is a major complication in the treatment of cancer, including multiple myeloma (MM). Patients may develop painful and nonpainful (e.g., numbness) neuropathy symptoms that impair function and often persist after therapy is terminated. This study tes...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3669643/ https://ncbi.nlm.nih.gov/pubmed/23543296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2152-7 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|